郑州做近视眼手术需要多少费用(郑州眼部激光手术多少钱) (今日更新中)

A rare and deadly complication from the coronavirus infection is now being reported in adults, after several deadly cases in children earlier this year.Multisystem inflammatory syndrome in children (MIS-C) was reported in teens and children after the start of the pandemic, with tragic outcomes. More than 1,000 cases have been reported to the CDC as of October, of those about 20 children have died.There are now more than two dozen reported cases in adults, according to the Centers for Disease Control and Prevention, and it is being called MIS-A, for “adults.”The CDC warns that symptoms of MIS-A can present in patients who did not have COVID-19 symptoms but later tested positive for COVID-19 antibodies.“These patients might not have positive SARS-CoV-2 PCR or antigen test results, and antibody testing might be needed to confirm previous SARS-CoV-2 infection. Because of the temporal association between MIS-A and SARS-CoV-2 infections, interventions that prevent COVID-19 might prevent MIS-A,” the CDC’s report states.In children, symptoms have included shock, cardiac dysfunction, abdominal pain, and elevated inflammatory signs. According to the CDC, there have been similar symptoms spotted in adults.“Findings indicate that adult patients of all ages with current or previous SARS-CoV-2 infection can develop a hyperinflammatory syndrome resembling MIS-C,” the CDC states.The CDC’s report looks at 16 patients who ranged in age from 21 to 50, of those, nine had no reported underlying medical conditions. Of the 16 patients tracked in the studies, two of them died.The time between a coronavirus infection and the development of MIS-A is unclear, and varied widely in the cases studied by the CDC.Some of the patients had tested positive for COVID-19 several days before they were admitted to the hospital with MIS-A symptoms, at least one patient tested positive 41 days before. A few of them had tested positive for COVID-19, then tested negative before they developed MIS-A. 1999

A new species of prehistoric reptile has apparently been discovered within the depths of the Petrified Forest National Park in northeastern Arizona.Named Skybalonyx skapter, the fossilized remains are believed to be a new species of drepanosaur, a reported 220-million-year-old burrowing reptile that potentially looked like a combination of an anteater and chameleon, the Petrified Forest National Park said Tuesday in a news release.Skybalonyx skapter, though, may have looked even more peculiar, the release said.Drepanosaurs have been noted to have interesting features, such as "enlarged second claws, bird-like beaks, and tails ending with a claw," the release said.The discovery was made by research teams from Petrified Forest National Park, Virginia Tech, University of Washington, Arizona State University, Idaho State University, and the Virginia Museum of Natural History, according to the release.Their findings were reportedly published on Oct. 8 in the Journal of Vertebrate Paleontology. The study compared the claws of drepanosaurs to Skybalonyx skapter to modern animals, and reportedly found that Skybaonyx skapter's claws were similar to moles, echidnas, and mole-rats.Adam Marsh, the lead paleontologist at the Petrified Forest, said in an email that the bones were discovered during the summers of 2018 and 2019 as part of a paleontological dig.Due to their small size, the remains were reportedly difficult to find using traditional methods. Essentially, research teams used a series of metal screens and water to sift and break down rocks to find the fossils.He said the bones were found in the eastern expansion of the forest that was acquired in 2011. He said more than 3,000 fossils have been discovered there in the last two years.As for the drepanosaurs project, he said "we are just starting this project, and we will be continuing to collect fossils from this and other sites."This story was originally published by Josh Frigerio at KNXV. 1977

A study conducted by Stanford researchers found nearly 10% of those tested exhibited coronavirus antibodies. The study was published in the Lancet earlier this week.The study involved dialysis patients and randomly tested over 28,000 samples. The samples were taken in July as part of the patients’ treatment.The data found stark differences based on region. The northeast around 27% of patients with coronavirus antibodies, compared to 3.5% in the west.The study’s authors stressed that the study oversampled minorities. Minorities, the study found, were considerably more likely to have coronavirus antibodies than the rest of the population.“Uncertainty exists as to whether seroprevalence estimates in the dialysis population can be extrapolated to the US population more broadly,” the study reads.The study indicated that herd immunity is still far off, as estimates say at a minimum, 50% of the US population would need to be infected to reach that level. 969

A self-driving vehicle operated by Waymo was involved in a crash in Chandler on Friday afternoon. Helicopter footage from Scripps station KNXV in Phoenix showed significant damage to the self-driving van, as well as a silver sedan, after the collision near Chandler Village Drive and Chandler Boulevard. Minor injuries were reported in the crash.Chandler police said the Waymo van was in autonomous mode with an occupant behind the wheel at the time of the crash, but was not the "violator vehicle."Police spokesman Seth Tyler said it is believed that this is the first Waymo collision in Chandler this year.RELATED: Waymo gives?360-degree?view of what it's like inside self-driving carsThis is the second known self-driving car crash in the Phoenix area in the past two months. An Uber self-driving vehicle hit and killed a?pedestrian in Tempe on March 19.After the March crash, Waymo CEO John Krafcik?said he was confident in his company's technology.In November 2017, Waymo?announced that self-driving cars would be tested in Chandler without someone in the driver's seat. Chandler police told KNXV that an operator was behind the wheel at the time of Friday's collision. KNXV has reached out to Waymo for a comment on the crash.Waymo is subsidiary of Google. The company was founded in 2009.  1359

A new disinfectant is proving effective against coronavirus. It's called SurfaceWise2.The Environmental Protection Agency (EPA) just gave the Allied BioScience product emergency use authorization.The disinfectant is the only long-lasting COVID-19 killer. It's sprayed on surfaces and kills the novel coronavirus and other viruses.“It’s a continuously self-cleaning surface, so as contaminants, germs, virus cells lands on the surface, the product is continuously and begins immediately killing those virus cells and pathogens,” said Jess Hilton, CMO at Allied BioScience.Its makers say testing proves it works for months. The EPA says it can kill coronavirus for us to seven days in one use. It's safe for surfaces and people."The EPA approval clears the way to begin effectively protecting consumers against COVID-19 as the only solution proven to provide long-term, non-toxic surface protection from the virus," said Allied BioScience CEO Michael Ruley in a press release. So far, the emergency use was approved for American Airlines planes and Texas-based companies. The state worked with the company on the waiver. Others are putting in waivers too.“The application opportunities for this product are sort of endless. Anywhere where you have public spaces for high traffic and therefore high contamination environments, this is a solution that goes in-between your daily cleaning,” said Hilton.The company says it costs about 40 to 50 cents per square foot per year to use the product. A large school bus has about 320 square feet of space. That's about 0 per bus a year.Allied BioScience didn’t come up with the disinfectant overnight. The company started making it as a product to kill hospital bacteria a dozen years ago. 1739

来源：资阳报